| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |